Exact Sciences’ 2020 had several notable events in 2020. Exact:
February: Completed 477,000 Cologuard tests in the fourth quarter of 2019 and 1.68 million tests in 2019.
March: Donates money to Fight Colorectal Cancer to launch the Catalyst State-by-State Advocacy Program. The program funds efforts to advance legislation that promotes CRC screening.
March 3: Acquires Paradigm and Viomics. The companies expand Exact’s lab testing and research and development capabilities.
March 19: Withdraws first-quarter and annual guidance for 2020 because of COVID-19. Allows employees to work remotely while maintaining laboratory testing capabilities to handle Cologuard tests.
May: Reports revenues of $347.8 million for the first quarter and a net loss of $105.7 million. Doesn’t report screening figures.
July: Reports revenues of $268.9 million for the quarter and a net loss of $86.1 million. Doesn’t report screening figures.
October: Introduces its Oncotype MAP Pan-Cancer Tissue test. The diagnostic test screens for advanced, metastatic, refractory or recurrent cancers. The test provides information to physicians to understand a patient’s tumor profile.
Oct. 7: Extends and amends its Cologuard promotion agreement with Pfizer. The agreement has been largely successful and has increased Cologuard adoption rates.
Oct. 27: Acquires Thrive for its CancerSeek platform. Claims it has become a leader in blood-based, multi-cancer screening.
Oct. 27: Revenues recover from COVID-19-related disruption. Reports $408.4 million in revenues and a net loss of $219.9 million. Doesn’t report testing figures.
December: Donates $10 million Stand Up To Cancer. The funds will be used to establish a team of researchers and launch a public awareness campaign around increasing screenings.
More articles on surgery centers:
Ohio health system acquires surgery center for $21M
2 Texas health systems suspend surgeries, others don’t
Stryker’s ASC-focused business: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
